FMI noted the EUDR-compliant pharma secondary carton board market was valued at USD 450.5 million in 2025. Sales are expected to reach USD 485.4 million in 2026 and USD 925.3 million by 2036. Bleached Board is projected to lead by Material Type with 44.5% share in 2026 and Prescription Drugs is anticipated to dominate by End Use through 2036.